![WCLC 2022 Conference Coverage](http://media.vumedi.com/thumbs/channel_logo/2022/8/1e11d80a-513e-4d37-b628-cc3988da4c0b.png.200x0_q85.png)
WCLC 2022 Conference Coverage
Playback speed
10 seconds
WCLC 2022 on the Single Arm Phase II Study PEMMELA: Pembrolizumab + Lenvatinib in 2L/3L Malignant Pleural Mesothelioma Patients
By
WCLC 2022 Conference Coverage
FEATURING
Li-Anne Huaqing Douma
By
WCLC 2022 Conference Coverage
FEATURING
Li-Anne Huaqing Douma
15 views
August 18, 2022
Login to view comments.
Click here to Login
Videos